Essex Bio-Technology Limited (01061) submitted its monthly return for equity issuers covering 31 October 2025. The total authorised share capital remained at HKD 100,000,000, representing 1,000,000,000 ordinary shares at a par value of HKD 0.1 each. No changes occurred in the issued share capital during this period, leaving the total issued shares at 567,006,000 with no treasury shares recorded.

Under the share option scheme approved on 9 June 2023, there were no share options outstanding at the start or end of October. However, 57,064,900 shares may be issued or transferred out of treasury pursuant to the scheme. No other agreements or arrangements to issue shares were disclosed, and no warrants or convertible instruments were reported. The submission date for the monthly return was 4 November 2025.